Cell Analysis Market

Cell Analysis Market by Product & Service (Reagents & Consumables, Instruments), Technique (Flow Cytometry, High Content Screening), Process (Single-cell Analysis), End User (Pharmaceutical and Biotechnology Companies) - Global Forecast to 2027

Report Code: BT 2358 May, 2022, by marketsandmarkets.com

[236 Pages Report] The global cell analysis market is projected to reach USD 28.6 billion by 2027 from USD 17.7 billion in 2022, at a CAGR of 10.1% during the forecast period. Strenghtened funding for cell-based research activities, elevating adoption of cell-based assays in drug discovery, and increase in the number of drug discovery activities collectively drive the growth of cell analysis market. Different market opportunities such as, widening of cell-based assay applications, the outbreak of COVID-19 pandemic, and lucrative opportunities offered by emerging economies further propel the market growth. However, high pricing of sophisticated cell analysis instruments along with the limitations on use of reagents is expected to hamper the growth of cell analysis market.

Cell Analysis Market

To know about the assumptions considered for the study, Request for Free Sample Report

Global Cell Analysis Market Dynamics

DRIVER: Rising preference for cell-based assays in drug discovery

The traditional methods of drug safety assessment that involve animal testing protocols are associated with high costs, offer low-throughput, and demand a lot of time. The latest cell-based assays combine the advantages of animal models and cell cultures which enable researchers to enhance the efficacy of lead identification in early screening. Additionally, the ability of cell-based assays to provide cost-effective and accelerated drug discovery solutions have propelled the market growth.

RESTRAINT: High cost of instruments and restrictions on reagent use

Sophisticated cell analysis technologies such as high content screening (HCS) have led to increase in instrument costs. In addition, the price and duration involved in each HTS process is directly impacted by the complexity of the targeted molecule. Thus, only certain group of end users are able to access novel cell analysis solutions. For instance, pharmaceutical and biopharmaceutical companies are at the forefront, whereas academic and research laboratories find it difficult to afford such expensive instruments due to budgetary restrictions. This hampers the overall adoption of cell analysis products to a certain extent further restraining the market growth.

OPPORTUNITY: Emerging economies

Emerging Asian economies offer profitable opportunities for market expansion with low costs associated with raw material. Additionally, a number of government authorities in the Asia Pacific region are focusing on life science research, specifically post the outbreak of the COVID-19 pandemic. For instance, the Global Health Innovative Technology (GHIT) Fund is a public-private partnership in Japan that funds various R&D activities for drug discovery, which also includes the screening of compound libraries related to various infectious diseases. R&D spending for new drug development is a critical growth driver for the global cell analysis assays industry.

The software segment registered the fastest growth rate in the cell analysis market during the forecast period

Based on product & service, the global cell analysis market is segmented into reagents & consumables, instruments, accessories, software, and services. The reagents & consumables segment accounted for the largest share of the cell analysis market in 2021. Key market players offer flow cytometry reagents as directly conjugated products. Launch of high-quality reagents by these companies has increased market availability of dry flow cytometry reagents contributing to the dominance of the reagents & consumables market. Whereas, software segment has registered highest CAGR during the forecast period. Development of datasets with complex designs and multiple modalities has led to the increasing need of computational methods and software tools for effective interpretation of these datasets, contributing to the segment growth.

The flow cytometry technique dominated the cell analysis market in 2021

Based on technique, the global cell analysis market is segmented into flow cytometry, PCR, cell microarrays, microscopy, spectrophotometry, high-content screening, and other techniques. The flow cytometry segment accounted for the largest market share in 2021. High adoption of flow cytometry in single-cell analysis applications attributed to its capacity to measure multiple parameters in a heterogeneous sample at single-cell level is the key contributive factor to the high market share represented by this segment. On the contrary, high-content screening segment is projected to register the highest CAGR during the forecast period. Growth in the number of cell behavior studies drives the segment growth. However, complexities associated with cell image acquisition and analysis workflows due to fluorescence illumination may hamper the segment’s revenue generation capacity to certain extent.

The single-cell analysis segment is expected to register the highest CAGR during the forecast period

Based on process, the global cell analysis market is segmented into cell identification, cell viability, cell signaling pathway/signal transduction, cell proliferation, cell counting & quality control, cell interaction, cell structure study, target identification & validation, and single-cell analysis. Cell identification accounted for the largest market share of in 2021. Cell identification serves as an important step in several industrial applications, including food and healthcare. Cell identification is critical In drug discovery wherein the cells are identified based on their response to a specific compound. The single-cell analysis segment is expected to register the highest CAGR during the forecast period. Single-cell analysis has gained significant traction over the years for assessment of individual cells at multi-parametric level, contributing to the segment growth.

The pharmaceutical & biotechnology companies accounted for the largest share in the cell analysis market in 2021

Based on end user, the cell analysis market is segmented into pharmaceutical & biotechnology companies, hospitals & clinical testing laboratories, academic & research institutes, and other end users. The other end users are inclusive of forensic laboratories, blood banks, CROs, food & beverage manufacturers, and environmental monitoring organizations. The pharmaceutical & biotechnology companies segment accounted for the largest market share in 2021. Routine use of instruments and consumables at various drug discovery & development stages contributes to the dominance of pharmaceutical & biotechnology in the cell analysis market. Whereas, hospitals and clinical testing laboratories segment is set to grow with the highest CAGR from 2022 to 2027. Adoption of highly complex and specialized assays across this end user segment is expected to support its rapid growth.

North America was the largest regional market for cell analysis in 2021.

Geographically, the cell analysis market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region ranked first in terms of revenue in 2021, followed by Europe. Favorable business environment, strong government support, and well established pharmaceutical & biotechnology companies in the US collectively contribute to the regional dominance. Asia Pacific cell analysis market is expected to grow at the fastest pace through 2022 to 2027. APAC countries are exhibiting sustained growth in their GDPs along with their disposable incomes. This has led to significant increase in the healthcare expenditure and improved penetration of advanced cell analysis technologies.

Cell Analysis Market  by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

Key players in the global cell analysis market include Danaher (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), General Electric (US), Merck KGaA (US), Agilent Technologies (US), Olympus Corporation (Japan), Miltenyi Biotec (US), Bio-Rad Laboratories (US), BioStatus Limited (UK), Fluidigm Corporation (US), NanoCellect Biomedical (US), Cell Biolabs (US), Creative Bioarray (US), Meiji Techno (US), Promega Corporation (US), PerkinElmer (US), Tecan Trading AG (Switzerland), CELLINK (US), QIAGEN (Germany), Corning Incorporated (US), 10x Genomics (US), and Illumina (US).

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size available for years

2020–2027

Base year considered

2021

Forecast period

2022–2027

Forecast units

Value (USD Billion)

Segments covered

Product & service, technique, process, end user, and region

Geographies covered

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa

Companies covered

Danaher (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), General Electric (US), Merck KGaA (US), Agilent Technologies (US), Olympus Corporation (Japan), Miltenyi Biotec (US), Bio-Rad Laboratories (US), BioStatus Limited (UK), Fluidigm Corporation (US), NanoCellect Biomedical (US), Cell Biolabs (US), Creative Bioarray (US), Meiji Techno (US), Promega Corporation (US), PerkinElmer (US), Tecan Trading AG (Switzerland), CELLINK (US), QIAGEN (Germany), Corning Incorporated (US), 10x Genomics (US), and Illumina (US)

This report categorizes the cell analysis market into the following segments:

By Product & Service

  • Reagents & Consumables
  • Instruments
  • Accessories
  • Software
  • Service

By Technique

  • Flow Cytometry
  • PCR
  • Cell Microarrays
  • Microscopy
  • Spectrophotometry
  • High Content Screening
  • Other Techniques

By Process

  • Cell Identification
  • Cell Viability
  • Cell Signaling Pathways/Signal Transduction
  • Cell Proliferation
  • Cell Counting and Quality Control
  • Cell Interaction
  • Cell Structure Study
  • Target Identification and Validation
  • Single-Cell Analysis

By End User

  • Pharmaceutical & Biotechnology Companies
  • Hospitals and Clinical Testing Laboratories
  • Academic and Research Institutes
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

Recent Developments

  • In 2022, Becton, Dickinson and Company (US) launched a high-throughput cell sorter that merges fluorescence with visual imaging. This product is suitable for research applications to identify and categorize cell populations at the single-cell level
  • In 2020, Agilent Technologies (US) launched NovoCyte Penteon, a sensitive flow cytometer with five lasers and up to 30 fluorescence channels.
  • In 2020, Thermo Fisher Scientific (US) completed the acquisition of phitonex, inc. This acquisition enabled thermo fisher to expand its flow cytometry and imaging multiplexing capabilities in protein and cell analysis research.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 32)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
           1.2.2 MARKETS COVERED
           1.2.3 YEARS CONSIDERED FOR THE STUDY
    1.3 CURRENCY
    1.4 LIMITATIONS
    1.5 STAKEHOLDERS
    1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 36)
    2.1 RESEARCH DATA
           FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 2 CELL ANALYSIS MARKET: BREAKDOWN OF PRIMARIES
    2.2 MARKET SIZE ESTIMATION
           FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP (SUPPLY SIDE)
           FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2020
           FIGURE 5 AVERAGE MARKET SIZE ESTIMATION (2021)
    2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
           FIGURE 6 CELL ANALYSIS MARKET: CAGR PROJECTIONS (2022–2027)
           FIGURE 7 CELL ANALYSIS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, AND OPPORTUNITIES
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
           FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.5 INSIGHTS FROM PRIMARIES
           FIGURE 9 MARKET VALIDATION FROM PRIMARY EXPERTS
    2.6 RESEARCH ASSUMPTIONS
           2.6.1 COVID-19-SPECIFIC ASSUMPTIONS
    2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY (Page No. - 47)
    FIGURE 10 CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)
    FIGURE 11 CELL ANALYSIS MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)
    FIGURE 12 CELL ANALYSIS MARKET, BY PROCESS, 2022 VS. 2027 (USD MILLION)
    FIGURE 13 CELL ANALYSIS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    FIGURE 14 GEOGRAPHICAL SNAPSHOT OF THE CELL ANALYSIS MARKET

4 PREMIUM INSIGHTS (Page No. - 52)
    4.1 CELL ANALYSIS MARKET OVERVIEW
           FIGURE 15 INCREASING FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET GROWTH
    4.2 NORTH AMERICA: CELL ANALYSIS MARKET SHARE, BY PRODUCT & SERVICE AND COUNTRY (2021)
           FIGURE 16 REAGENTS & CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021
    4.3 NORTH AMERICA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)
           FIGURE 17 FLOW CYTOMETRY SEGMENT WILL CONTINUE TO DOMINATE NORTH AMERICAN MARKET IN 2027

5 MARKET OVERVIEW (Page No. - 55)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 18 CELL ANALYSIS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
           TABLE 1 CELL ANALYSIS MARKET: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Rising preference for cell-based assays in drug discovery
                    5.2.1.2 Increasing funding for cell-based research
                    5.2.1.3 Growing number of drug discovery activities
           5.2.2 RESTRAINT
                    5.2.2.1 High cost of instruments and restrictions on reagent use
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emerging economies
                    5.2.3.2 Growing risk of pandemics and communicable diseases
                    5.2.3.3 Application of novel cell-based assays in cancer research
    5.3 PORTER’S FIVE FORCES ANALYSIS
           TABLE 2 CELL ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.3.1 THREAT OF NEW ENTRANTS
           5.3.2 THREAT OF SUBSTITUTES
           5.3.3 BARGAINING POWER OF BUYERS
           5.3.4 BARGAINING POWER OF SUPPLIERS
           5.3.5 DEGREE OF COMPETITION
    5.4 IMPACT OF COVID-19 ON THE CELL ANALYSIS MARKET
    5.5 SUPPLY CHAIN ANALYSIS
           FIGURE 19 CELL ANALYSIS MARKET: SUPPLY CHAIN ANALYSIS (CELL-BASED ASSAYS)
    5.6 VALUE CHAIN ANALYSIS
           FIGURE 20 CELL ANALYSIS MARKET: VALUE CHAIN ANALYSIS
    5.7 ECOSYSTEM ANALYSIS
           FIGURE 21 CELL ANALYSIS MARKET: ECOSYSTEM ANALYSIS
    5.8 REGULATORY ANALYSIS (FLOW CYTOMETRY-BASED CELL ANALYSIS)
           5.8.1 STRINGENT FDA REQUIREMENTS
           5.8.2 STRINGENT ANALYTE-SPECIFIC REAGENT RULE
           5.8.3 LACK OF WELL-DEFINED VALIDATION PROTOCOLS FOR CELL-BASED ASSAYS
           5.8.4 ABSENCE OF ESTABLISHED LABORATORY-DEVELOPED TEST GUIDELINES ON CELL-BASED FLUORESCENCE ASSAYS
           5.8.5 GREATER GLOBAL RECOGNITION FOR IVD CE MARK APPROVALS
           5.8.6 US REIMBURSEMENT SCENARIO
    5.9 TECHNOLOGY ANALYSIS
           FIGURE 22 TECHNOLOGY ANALYSIS: CELL ANALYSIS MARKET
    5.10 KEY CONFERENCES & EVENTS, 2021–2022
           5.10.1 CELL ANALYSIS CONFERENCES, 2022
                    TABLE 3 CELL ANALYSIS CONFERENCES (2022)
           5.10.2 CELL ANALYSIS CONFERENCES, 2021
                    TABLE 4 CELL ANALYSIS CONFERENCES (2021)
    5.11 PRICING ANALYSIS
           5.11.1 AVERAGE SELLING PRICES OF CELL ANALYSIS PRODUCTS & SERVICES
                    TABLE 5 AVERAGE SELLING PRICES OF CELL ANALYSIS PRODUCTS & SERVICES (TOP 5)
FALSE
           5.11.2 AVERAGE SELLING PRICE TREND

6 CELL ANALYSIS MARKET, BY PRODUCT & SERVICE (Page No. - 70)
    6.1 INTRODUCTION
           TABLE 6 CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
    6.2 REAGENTS & CONSUMABLES
           6.2.1 ADVENT OF NOVEL CELL ANALYSIS KITS & REAGENTS FOR FLOW CYTOMETRY TO BOOST SEGMENT GROWTH
                    TABLE 7 CELL ANALYSIS REAGENTS & CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 8 NORTH AMERICA: CELL ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 9 EUROPE: CELL ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 10 ASIA PACIFIC: CELL ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.3 INSTRUMENTS
           6.3.1 INNOVATIONS IN CELL ANALYSIS INSTRUMENTS FOR DRUG DISCOVERY RESEARCH TO DRIVE MARKET GROWTH
                    TABLE 11 CELL ANALYSIS INSTRUMENTS MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 12 NORTH AMERICA: CELL ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 13 EUROPE: CELL ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 14 ASIA PACIFIC: CELL ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.4 ACCESSORIES
           6.4.1 FLOW CYTOMETRY ACCESSORIES ENABLE END USERS TO CUSTOMIZE FLOW CYTOMETRY INSTRUMENTS
                    TABLE 15 CELL ANALYSIS ACCESSORIES MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 16 NORTH AMERICA: CELL ANALYSIS ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 17 EUROPE: CELL ANALYSIS ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 18 ASIA PACIFIC: CELL ANALYSIS ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.5 SOFTWARE
           6.5.1 EXPANDING POOL OF KEY PLAYERS INTRODUCING UNIQUE SOFTWARE OR DATA INTERPRETATION TOOLS PROPELS SEGMENT GROWTH
                    TABLE 19 CELL ANALYSIS SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 20 NORTH AMERICA: CELL ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 21 EUROPE: CELL ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 22 ASIA PACIFIC: CELL ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.6 SERVICES
           6.6.1 REMOTE SERVICES ENSURE WORKFLOW CONTINUITY AND MAXIMIZE PERFORMANCE
                    TABLE 23 CELL ANALYSIS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 24 NORTH AMERICA: CELL ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 25 EUROPE: CELL ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 26 ASIA PACIFIC: CELL ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

7 CELL ANALYSIS MARKET, BY TECHNIQUE (Page No. - 82)
    7.1 INTRODUCTION
           TABLE 27 CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
    7.2 FLOW CYTOMETRY
           7.2.1 ABILITY TO PERFORM MULTIPLE MEASUREMENTS ON SINGLE CELLS IS KEY ADVANTAGE ASSOCIATED WITH THIS TECHNIQUE
                    TABLE 28 CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 29 NORTH AMERICA: CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 30 EUROPE: CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 31 ASIA PACIFIC: CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2020–2027 (USD MILLION)
    7.3 PCR
           7.3.1 DIGITAL PCR CAN EFFECTIVELY MEASURE AND MONITOR RARE SEQUENCES
                    TABLE 32 CELL ANALYSIS MARKET FOR PCR, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 33 NORTH AMERICA: CELL ANALYSIS MARKET FOR PCR, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 34 EUROPE: CELL ANALYSIS MARKET FOR PCR, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 35 ASIA PACIFIC: CELL ANALYSIS MARKET FOR PCR, BY COUNTRY, 2020–2027 (USD MILLION)
    7.4 CELL MICROARRAYS
           7.4.1 CELL MICROARRAYS ARE USED IN DESIGNING AND CONTROLLING STEM CELLS IN TISSUE ENGINEERING
                    TABLE 36 CELL ANALYSIS MARKET FOR CELL MICROARRAYS, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 37 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL MICROARRAYS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 38 EUROPE: CELL ANALYSIS MARKET FOR CELL MICROARRAYS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 39 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL MICROARRAYS, BY COUNTRY, 2020–2027 (USD MILLION)
    7.5 MICROSCOPY
           7.5.1 RISING INCIDENCE OF CANCER AND GROWING INVESTMENTS IN CELL BIOLOGY TO DRIVE MARKET GROWTH
                    TABLE 40 CELL ANALYSIS MARKET FOR MICROSCOPY, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 41 NORTH AMERICA: CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 42 EUROPE: CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 43 ASIA PACIFIC: CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2020–2027 (USD MILLION)
    7.6 SPECTROPHOTOMETRY
           7.6.1 HIGH DEMAND FOR SPECTROPHOTOMETERS IN RESEARCH SETTINGS TO SUPPORT MARKET GROWTH
                    TABLE 44 CELL ANALYSIS MARKET FOR SPECTROPHOTOMETRY, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 45 NORTH AMERICA: CELL ANALYSIS MARKET FOR SPECTROPHOTOMETRY, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 46 EUROPE: CELL ANALYSIS MARKET FOR SPECTROPHOTOMETRY, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 47 ASIA PACIFIC: CELL ANALYSIS MARKET FOR SPECTROPHOTOMETRY, BY COUNTRY, 2020–2027 (USD MILLION)
    7.7 HIGH-CONTENT SCREENING (HCS)
           7.7.1 HIGH DEMAND FOR HCS IN CELL BEHAVIOR RESEARCH STUDIES TO SUPPORT SEGMENT GROWTH
                    TABLE 48 CELL ANALYSIS MARKET FOR HIGH-CONTENT SCREENING, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 49 NORTH AMERICA: CELL ANALYSIS MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 50 EUROPE: CELL ANALYSIS MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 51 ASIA PACIFIC: CELL ANALYSIS MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2020–2027 (USD MILLION)
    7.8 OTHER TECHNIQUES
           TABLE 52 CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY REGION, 2020–2027 (USD MILLION)
           TABLE 53 NORTH AMERICA: CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 54 EUROPE: CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2020–2027 (USD MILLION)
           TABLE 55 ASIA PACIFIC: CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2020–2027 (USD MILLION)

8 CELL ANALYSIS MARKET, BY PROCESS (Page No. - 98)
    8.1 INTRODUCTION
           TABLE 56 CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
    8.2 CELL IDENTIFICATION
           8.2.1 INCREASING RESEARCH ACTIVITIES TO PROPEL MARKET GROWTH
                    TABLE 57 CELL ANALYSIS MARKET FOR CELL IDENTIFICATION, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 58 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL IDENTIFICATION, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 59 EUROPE: CELL ANALYSIS MARKET FOR CELL IDENTIFICATION, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 60 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL IDENTIFICATION, BY COUNTRY, 2020–2027 (USD MILLION)
    8.3 CELL VIABILITY
           8.3.1 CELL VIABILITY IS USED TO CORRELATE CELL BEHAVIOR TO CELL NUMBERS
                    TABLE 61 CELL ANALYSIS MARKET FOR CELL VIABILITY, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 62 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL VIABILITY, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 63 EUROPE: CELL ANALYSIS MARKET FOR CELL VIABILITY, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 64 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL VIABILITY, BY COUNTRY, 2020–2027 (USD MILLION)
    8.4 CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION
           8.4.1 HIGH DEMAND FOR TOXICITY TESTING IN DRUG DEVELOPMENT TO DRIVE MARKET GROWTH
                    TABLE 65 CELL ANALYSIS MARKET FOR CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 66 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 67 EUROPE: CELL ANALYSIS MARKET FOR CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 68 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION, BY COUNTRY, 2020–2027 (USD MILLION)
    8.5 CELL PROLIFERATION
           8.5.1 CELL PROLIFERATION IS MEASURED ON THE BASIS OF AVERAGE DNA CONTENT
                    TABLE 69 CELL ANALYSIS MARKET FOR CELL PROLIFERATION, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 70 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL PROLIFERATION, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 71 EUROPE: CELL ANALYSIS MARKET FOR CELL PROLIFERATION, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 72 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL PROLIFERATION, BY COUNTRY, 2020–2027 (USD MILLION)
    8.6 CELL COUNTING & QUALITY CONTROL
           8.6.1 FLOW CYTOMETRY ENABLES EASY DIFFERENTIATION OF CELLS VIA SCATTERING OR STAINING
                    TABLE 73 CELL ANALYSIS MARKET FOR CELL COUNTING & QUALITY CONTROL, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 74 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL COUNTING & QUALITY CONTROL, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 75 EUROPE: CELL ANALYSIS MARKET FOR CELL COUNTING & QUALITY CONTROL, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 76 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL COUNTING & QUALITY CONTROL, BY COUNTRY, 2020–2027 (USD MILLION)
    8.7 CELL INTERACTION
           8.7.1 INCREASING ADVANCEMENTS IN CELL-CELL INTERACTIONS/CELL-CELL COMMUNICATION TO BOOST MARKET GROWTH
                    TABLE 77 CELL ANALYSIS MARKET FOR CELL INTERACTION, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 78 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL INTERACTION, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 79 EUROPE: CELL ANALYSIS MARKET FOR CELL INTERACTION, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 80 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL INTERACTION, BY COUNTRY, 2020–2027 (USD MILLION)
    8.8 CELL STRUCTURE STUDY
           8.8.1 ADVANCEMENTS IN CELLULAR IMAGING TO SUPPORT MARKET GROWTH
                    TABLE 81 CELL ANALYSIS MARKET FOR CELL STRUCTURE STUDY, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 82 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL STRUCTURE STUDY, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 83 EUROPE: CELL ANALYSIS MARKET FOR CELL STRUCTURE STUDY, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 84 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL STRUCTURE STUDY, BY COUNTRY, 2020–2027 (USD MILLION)
    8.9 TARGET IDENTIFICATION & VALIDATION
           8.9.1 HCS IN TARGET IDENTIFICATION IS USED TO IDENTIFY NOVEL TARGETS THROUGH SCREENING OF CELLULAR PATHWAYS
                    TABLE 85 CELL ANALYSIS MARKET FOR TARGET IDENTIFICATION & VALIDATION, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 86 NORTH AMERICA: CELL ANALYSIS MARKET FOR TARGET IDENTIFICATION & VALIDATION, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 87 EUROPE: CELL ANALYSIS MARKET FOR TARGET IDENTIFICATION & VALIDATION, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 88 ASIA PACIFIC: CELL ANALYSIS MARKET FOR TARGET IDENTIFICATION & VALIDATION, BY COUNTRY, 2020–2027 (USD MILLION)
    8.10 SINGLE-CELL ANALYSIS
           8.10.1 EXPANDING APPLICATIONS OF SINGLE-CELL ANALYSIS IN CLINICAL RESEARCH TO PROPEL SEGMENT GROWTH
                    TABLE 89 CELL ANALYSIS MARKET FOR SINGLE-CELL ANALYSIS, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 90 NORTH AMERICA: CELL ANALYSIS MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 91 EUROPE: CELL ANALYSIS MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 92 ASIA PACIFIC: CELL ANALYSIS MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2020–2027 (USD MILLION)

9 CELL ANALYSIS MARKET, BY END USER (Page No. - 121)
    9.1 INTRODUCTION
           TABLE 93 CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
           9.2.1 HIGH DEMAND FOR CELL-BASED RESEARCH IN DRUG DISCOVERY & DEVELOPMENT PROCESS CONTRIBUTES TO SEGMENT GROWTH
                    TABLE 94 CELL ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 95 CELL ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 96 NORTH AMERICA: CELL ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 97 EUROPE: CELL ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 98 ASIA PACIFIC: CELL ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
    9.3 HOSPITALS & CLINICAL TESTING LABORATORIES
           9.3.1 DEVELOPMENT OF COMPLEX & HIGHLY SPECIALIZED TESTS AND ASSAYS SUPPORTS MARKET GROWTH
                    TABLE 99 CELL ANALYSIS MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 100 NORTH AMERICA: CELL ANALYSIS MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 101 EUROPE: CELL ANALYSIS MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 102 ASIA PACIFIC: CELL ANALYSIS MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
    9.4 ACADEMIC & RESEARCH INSTITUTES
           9.4.1 GROWING NUMBER OF RESEARCH PROJECTS THROUGH INDUSTRY-ACADEMIA COLLABORATIONS TO DRIVE MARKET GROWTH
                    TABLE 103 CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 104 NORTH AMERICA: CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 105 EUROPE: CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 106 ASIA PACIFIC: CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
    9.5 OTHER END USERS
                    TABLE 107 CELL ANALYSIS MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 108 NORTH AMERICA: CELL ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 109 EUROPE: CELL ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 110 ASIA PACIFIC: CELL ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)

10 CELL ANALYSIS MARKET, BY REGION (Page No. - 133)
     10.1 INTRODUCTION
               TABLE 111 CELL ANALYSIS MARKET, BY REGION, 2020–2027 (USD MILLION)
     10.2 NORTH AMERICA
               FIGURE 23 NORTH AMERICA: CELL ANALYSIS MARKET SNAPSHOT
               TABLE 112 NORTH AMERICA: CELL ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
               TABLE 113 NORTH AMERICA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
               TABLE 114 NORTH AMERICA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
               TABLE 115 NORTH AMERICA: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
               TABLE 116 NORTH AMERICA: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.2.1 US
                       10.2.1.1 US dominates North American cell analysis market
                                   TABLE 117 US: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                   TABLE 118 US: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                   TABLE 119 US: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
                                   TABLE 120 US: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.2.2 CANADA
                       10.2.2.1 Increasing government initiatives targeted toward stem cell research to drive market growth
                                   TABLE 121 CANADA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                   TABLE 122 CANADA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                   TABLE 123 CANADA: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
                                   TABLE 124 CANADA: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.3 EUROPE
               TABLE 125 EUROPE: CELL ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
               TABLE 126 EUROPE: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
               TABLE 127 EUROPE: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
               TABLE 128 EUROPE: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
               TABLE 129 EUROPE: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.1 GERMANY
                       10.3.1.1 Strong R&D infrastructure, training, and awareness programs ensure market growth in Germany
                                   TABLE 130 GERMANY: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                   TABLE 131 GERMANY: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                   TABLE 132 GERMANY: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
                                   TABLE 133 GERMANY: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.2 FRANCE
                       10.3.2.1 Presence of large biotechnology industry favors market growth
                                   TABLE 134 FRANCE: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                   TABLE 135 FRANCE: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                   TABLE 136 FRANCE: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
                                   TABLE 137 FRANCE: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.3 UK
                       10.3.3.1 Growing acceptance of flow cytometry products for clinical diagnostics to drive market growth
                                   TABLE 138 UK: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                   TABLE 139 UK: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                   TABLE 140 UK: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
                                   TABLE 141 UK: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.4 ITALY
                       10.3.4.1 Increasing research activities and conferences to support market growth
                                   TABLE 142 ITALY: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                   TABLE 143 ITALY: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                   TABLE 144 ITALY: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
                                   TABLE 145 ITALY: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.5 SPAIN
                       10.3.5.1 Growing focus on cancer diagnosis increased flow cytometry product usage in Spain
                                   TABLE 146 SPAIN: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                   TABLE 147 SPAIN: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                   TABLE 148 SPAIN: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
                                   TABLE 149 SPAIN: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.6 REST OF EUROPE
                       TABLE 150 REST OF EUROPE: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                       TABLE 151 REST OF EUROPE: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                       TABLE 152 REST OF EUROPE: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
                       TABLE 153 REST OF EUROPE: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.4 ASIA PACIFIC
               FIGURE 24 ASIA PACIFIC: CELL ANALYSIS MARKET SNAPSHOT
               TABLE 154 ASIA PACIFIC: CELL ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
               TABLE 155 ASIA PACIFIC: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
               TABLE 156 ASIA PACIFIC: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
               TABLE 157 ASIA PACIFIC: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
               TABLE 158 ASIA PACIFIC: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.1 JAPAN
                       10.4.1.1 Easy access to technologically advanced cell analysis products to favor market growth
                                   TABLE 159 JAPAN: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                   TABLE 160 JAPAN: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                   TABLE 161 JAPAN: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
                                   TABLE 162 JAPAN: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.2 CHINA
                       10.4.2.1 Developments in biotechnology sector to support market growth
                                   TABLE 163 CHINA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                   TABLE 164 CHINA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                   TABLE 165 CHINA: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
                                   TABLE 166 CHINA: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.3 INDIA
                       10.4.3.1 Government initiatives to drive market growth in India
                                   TABLE 167 INDIA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                                   TABLE 168 INDIA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                                   TABLE 169 INDIA: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
                                   TABLE 170 INDIA: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.4 REST OF ASIA PACIFIC
                       TABLE 171 REST OF ASIA PACIFIC: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                       TABLE 172 REST OF ASIA PACIFIC: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                       TABLE 173 REST OF ASIA PACIFIC: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
                       TABLE 174 REST OF ASIA PACIFIC: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.5 LATIN AMERICA
             10.5.1 GROWING PARTICIPATION OF ACADEMIC INSTITUTES IN RESEARCH TO ACCELERATE MARKET GROWTH
                       TABLE 175 LATIN AMERICA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                       TABLE 176 LATIN AMERICA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                       TABLE 177 LATIN AMERICA: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
                       TABLE 178 LATIN AMERICA: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA
             10.6.1 GROWING RESEARCH ACTIVITIES WILL FUEL DEMAND FOR CELL ANALYSIS PRODUCTS
                       TABLE 179 MIDDLE EAST & AFRICA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
                       TABLE 180 MIDDLE EAST & AFRICA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
                       TABLE 181 MIDDLE EAST & AFRICA: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
                       TABLE 182 MIDDLE EAST & AFRICA: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 177)
     11.1 INTRODUCTION
     11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
               FIGURE 25 CELL ANALYSIS MARKET: STRATEGIES ADOPTED
     11.3 MARKET SHARE ANALYSIS
               FIGURE 26 CELL ANALYSIS MARKET SHARE ANALYSIS (2021)
     11.4 REVENUE SHARE ANALYSIS (TOP 7 MARKET PLAYERS)
               FIGURE 27 REVENUE ANALYSIS FOR KEY COMPANIES, 2018–2021
     11.5 COMPANY EVALUATION QUADRANT
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
                       FIGURE 28 CELL ANALYSIS MARKET: COMPANY EVALUATION MATRIX, 2021
     11.6 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/ SMES/START-UPS (2021)
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 STARTING BLOCKS
             11.6.3 RESPONSIVE COMPANIES
             11.6.4 DYNAMIC COMPANIES
                       FIGURE 29 CELL ANALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS, 2021
     11.7 COMPETITIVE SCENARIO AND TRENDS
             11.7.1 PRODUCT LAUNCHES
                       TABLE 183 CELL ANALYSIS MARKET: PRODUCT LAUNCHES
             11.7.2 DEALS
                       TABLE 184 CELL ANALYSIS MARKET: DEALS
             11.7.3 OTHER DEVELOPMENTS
                       TABLE 185 CELL ANALYSIS MARKET: OTHER DEVELOPMENTS

12 COMPANY PROFILES (Page No. - 187)
     12.1 KEY COMPANIES
(Business Overview, Products Offered, Recent Developments, and MnM View)*
             12.1.1 THERMO FISHER SCIENTIFIC INC.
                       TABLE 186 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
                       FIGURE 30 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2020)
                       TABLE 187 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS
                       TABLE 188 THERMO FISHER SCIENTIFIC: PRODUCT LAUNCH
                       TABLE 189 THERMO FISHER SCIENTIFIC INC.: DEALS
             12.1.2 DANAHER
                       TABLE 190 DANAHER: BUSINESS OVERVIEW
                       FIGURE 31 DANAHER: COMPANY SNAPSHOT (2021)
                       TABLE 191 DANAHER: PRODUCT OFFERINGS
                       TABLE 192 DANAHER: DEALS
                       TABLE 193 DANAHER: OTHER DEVELOPMENTS
             12.1.3 BECTON, DICKINSON AND COMPANY (BD)
                       TABLE 194 BD: BUSINESS OVERVIEW
                       FIGURE 32 BD: COMPANY SNAPSHOT (2021)
                       TABLE 195 BD: PRODUCT OFFERINGS
                       TABLE 196 BD: PRODUCT LAUNCH
             12.1.4 GENERAL ELECTRIC
                       TABLE 197 GE: BUSINESS OVERVIEW
                       FIGURE 33 GE: COMPANY SNAPSHOT (2021)
                       TABLE 198 GE: PRODUCT OFFERINGS
                       TABLE 199 GE HEALTHCARE: OTHER DEVELOPMENTS
             12.1.5 MERCK KGAA
                       TABLE 200 MERCK KGAA: BUSINESS OVERVIEW
                       FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2021)
                       TABLE 201 MERCK KGAA: PRODUCT OFFERINGS
                       TABLE 202 MERCK KGAA: DEALS
             12.1.6 AGILENT TECHNOLOGIES, INC.
                       TABLE 203 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
                       FIGURE 35 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2021)
                       TABLE 204 AGILENT TECHNOLOGIES, INC.: PRODUCT OFFERINGS
                       TABLE 205 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES
             12.1.7 BIO-RAD LABORATORIES, INC.
                       TABLE 206 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
                       FIGURE 36 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)
                       TABLE 207 BIO-RAD LABORATORIES, INC.: PRODUCT OFFERINGS
                       TABLE 208 BIO-RAD LABORATORIES, INC.: DEALS
             12.1.8 FLUIDIGM CORPORATION
                       TABLE 209 FLUIDIGM CORPORATION: BUSINESS OVERVIEW
                       FIGURE 37 FLUIDIGM CORPORATION: COMPANY SNAPSHOT (2021)
                       TABLE 210 FLUIDIGM CORPORATION: PRODUCT OFFERINGS
                       TABLE 211 FLUIDIGM CORPORATION: DEALS
             12.1.9 MILTENYI BIOTEC
                       TABLE 212 MILTENYI BIOTEC: BUSINESS OVERVIEW
                       TABLE 213 MILTENYI BIOTEC: PRODUCT OFFERINGS
                       TABLE 214 MILTENYI BIOTEC: PRODUCT LAUNCHES
             12.1.10 OLYMPUS CORPORATION
                       TABLE 215 OLYMPUS CORPORATION: BUSINESS OVERVIEW
                       FIGURE 38 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2021)
                       TABLE 216 OLYMPUS CORPORATION: PRODUCT OFFERINGS
             12.1.11 BIOSTATUS LIMITED
                       TABLE 217 BIOSTATUS LIMITED: BUSINESS OVERVIEW
                       TABLE 218 BIOSTATUS LIMITED: PRODUCT OFFERINGS
             12.1.12 NANOCELLECT BIOMEDICAL
                       TABLE 219 NANOCELLECT BIOMEDICAL: BUSINESS OVERVIEW
                       TABLE 220 NANOCELLECT BIOMEDICAL: PRODUCT OFFERINGS
                       TABLE 221 NANOCELLECT BIOMEDICAL: DEALS
                       TABLE 222 NANOCELLECT BIOMEDICAL: PRODUCT LAUNCH
             12.1.13 CELL BIOLABS, INC.
                       TABLE 223 CELL BIOLABS, INC: BUSINESS OVERVIEW
                       TABLE 224 CELL BIOLABS, INC.: PRODUCT OFFERINGS
             12.1.14 CREATIVE BIOARRAY
                       TABLE 225 CREATIVE BIOARRAY: BUSINESS OVERVIEW
             12.1.15 MEIJI TECHNO
                                   TABLE 226 MEIJI TECHNO: BUSINESS OVERVIEW
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
     12.2 OTHER PLAYERS
             12.2.1 PROMEGA CORPORATION
                       TABLE 227 PROMEGA CORPORATION: COMPANY OVERVIEW
             12.2.2 PERKINELMER
                       TABLE 228 PERKINELMER: COMPANY OVERVIEW
             12.2.3 TECAN TRADING AG
                       TABLE 229 TECAN TRADING AG: COMPANY OVERVIEW
             12.2.4 CARL ZEISS
                       TABLE 230 CARL ZEISS: COMPANY OVERVIEW
             12.2.5 SYSMEX AMERICA, INC.
                       TABLE 231 SYSMEX AMERICA, INC.: COMPANY OVERVIEW
             12.2.6 CELLINK
                       TABLE 232 CELLINK: COMPANY OVERVIEW
             12.2.7 QIAGEN
                       TABLE 233 QIAGEN: COMPANY OVERVIEW
             12.2.8 ILLUMINA, INC.
                       TABLE 234 ILLUMINA, INC.: COMPANY OVERVIEW
             12.2.9 CORNING INCORPORATED
                       TABLE 235 CORNING INCORPORATED: COMPANY OVERVIEW
             12.2.10 10X GENOMICS
                       TABLE 236 10X GENOMICS: COMPANY OVERVIEW

13 APPENDIX (Page No. - 230)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

This study involved four major activities in estimating the current size of the cell analysis market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the cell analysis market. The secondary sources used for this study include World Health Organization (WHO), Organisation for Economic Co-operation and Development (OECD), International Society for Advancement of Cytometry (ISAC), International Society for Stem Cell Research (ISSCR), International Agency for Research on Cancer (IARC), Centers for Disease Control and Prevention (CDC), Society for Laboratory Automation and Screening (SLAS), Centers for Medicare & Medicaid Services (CMS), National Cancer Institute (NCI), European Commission (EC), American Society for Cell Biology (ASCB), European Society for Toxicology In Vitro (ESTIV), European Federation of Pharmaceutical Industries and Associations (EFPIA), Japan Society for Cell Biology (JSCB), Shanghai Institute of Biochemistry and Cell Biology (SIBCB), Indian Society of Cell Biology (ISCB), Food and Drug Administration (FDA), Society of Biomolecular Imaging and Informatics (SBI2), Annual Reports, SEC Filings, Investor Presentations, Press Releases, Conferences, Journals, Expert Interviews, and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Cell Analysis Market  Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the cell analysis market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the cell analysis business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the global cell analysis market based on the product & service, technique, process, end user and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, and opportunities)
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall cell analysis market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
  • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the cell analysis market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Company Information

  • An additional five company profiles
Report Code
BT 2358
Published ON
May, 2022
Choose License Type
BUY NOW
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Cell Analysis Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved